Skip to main content
Equibles

MORGAN STANLEY

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 895421 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$44,184,170
+$5,085,495 QoQ
Shares Held
9,461,279
-0.1% QoQ
Ownership
9.54%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 89 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. XFOR ranks #65 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in XFOR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,184,170 9,461,279
2026-03-31 $39,098,675 9,466,992
2025-12-31 $32,832,060 8,208,015
2025-09-30 $12,748 3,728
2025-06-30 $20,754 10,924
2025-03-31 $134,520 570,011
2024-12-31 $404,062 550,495
2024-09-30 $328,252 490,664
2024-06-30 $133,013 229,336
2024-03-31 $1,954,927 1,406,425
2023-12-31 $336,751 401,374
2023-09-30 $263,499 241,744
2023-06-30 $385,755 198,844
2023-03-31 $66,296 76,205
2022-12-31 $75,522 76,057
2022-09-30 $97,874 57,237
2022-06-30 $3,063 3,177
2022-03-31 $15,589 8,909
2021-12-31 $27,610 12,058
2021-09-30 $46,550 8,800
2021-06-30 $66,569 10,242
2021-03-31 $26,895 3,124
2020-12-31 $141,895 22,068
2020-09-30 $113,964 16,834
2020-06-30 $202,317 21,708
2020-03-31 $40,538 4,054